Impaired nociception and peripheral opioid antinociception in mice lacking both kinin b1 and b2 receptors

Anesthesiology

Volumn 116, Issue 2, 2012, Pages 448-457

  Cayla, Cecile ^a   Labuz, Dominika ^a   MacHelska, Halina ^a   Bader, Michael ^a   Schäfer, Michael ^b   Stein, Christoph ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; CARRAGEENAN; DELTA OPIATE RECEPTOR; FREUND ADJUVANT; MU OPIATE RECEPTOR; OPIATE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HEAT; HYPERSENSITIVITY; INFLAMMATION; KNOCKOUT MOUSE; MALE; MECHANICAL STIMULATION; MOUSE; NERVE COMPRESSION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; SCIATIC NERVE; VISCERAL PAIN; WILD TYPE;

ANALGESICS, OPIOID; ANIMALS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOCICEPTION; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; SCIATIC NEUROPATHY;

EID: 84856427872     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318242b2ea     Document Type: Article

References (71)

1. Bhoola KD, Figueroa CD, Worthy K: Bioregulation of kinins: Kallikreins, kininogens, and kininasE.S. Pharmacol Rev 1992; 44:1-80
2. Couture R, Harrisson M, Vianna RM, Cloutier F: Kinin receptors in pain and inflammation. Eur J Pharmacol 2001; 429: 161-76 (Pubitemid 33043994)
3. Dray A: Kinins and their receptors in hyperalgesia. Can J Physiol Pharmacol 1997; 75:704-12 (Pubitemid 27458660)
4. Wang H, Ehnert C, Brenner GJ, Woolf CJ: Bradykinin and peripheral sensitization. Biol Chem 2006; 387:11-4 (Pubitemid 43089589)
5. Burgess GM, Mullaney I, McNeill M, Dunn PM, Rang HP: Second messengers involved in the mechanism of action of bradykinin in sensory neurons in culture. J Neurosci 1989; 9:3314-25 (Pubitemid 19260844)
6. Sugiura T, Tominaga M, Katsuya H, Mizumura K: Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor. J Neurophysiol 2002; 88:544-8 (Pubitemid 34755376)
7. Berg KA, Patwardhan AM, Sanchez TA, Silva YM, Hargreaves KM, Clarke WP: Rapid modulation of micro-opioid receptor signaling in primary sensory neurons. J Pharmacol Exp Ther 2007; 321:839-47 (Pubitemid 46762685)
8. Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, Hargreaves KM: Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J Neurosci 2005; 25:8825-32 (Pubitemid 41384450)
9. Rowan MP, Ruparel NB, Patwardhan AM, Berg KA, Clarke WP, Hargreaves KM: Peripheral delta opioid receptors require priming for functional competence in vivo. Eur J Pharmacol 2009; 602:283-7
10. Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL: International Union of Pharmacology XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequencE.S. Pharmacol Rev 2005; 57:27-77 (Pubitemid 40283969)
11. Walker K, Perkins M, Dray A: Kinins and kinin receptors in the nervous system. Neurochem Int 1995; 26:1-16; discussion 17-26
12. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM: Kinin B1 receptors: Key G-protein-coupled receptors and their role in inflammatory and painful processE.S. Br J Pharmacol 2004; 143:803-18 (Pubitemid 39664839)
13. Duchene J, Ahluwalia A: The kinin B(1) receptor and inflammation: New therapeutic target for cardiovascular disease. Curr Opin Pharmacol 2009; 9:125-31
14. Marceau F, Hess JF, Bachvarov DR: The B1 receptors for kinins. Pharmacol Rev 1998; 50:357-86
15. de Campos RO, Alves RV, Ferreira J, Kyle DJ, Chakravarty S, Mavunkel BJ, Calixto JB: Oral antinociception and oedema inhibition produced by NPC 18884, a non-peptidic bradykinin B2 receptor antagonist. Naunyn Schmiedebergs Arch Pharmacol 1999; 360:278-86 (Pubitemid 29480918)
16. Heapy CG, Shaw JS, Farmer SC: Differential sensitivity of antinociceptive assays to the bradykinin antagonist Hoe 140. Br J Pharmacol 1993; 108:209-13 (Pubitemid 23007433)
17. Corrêa CR, Calixto JB: Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse. Br J Pharmacol 1993; 110:193-8 (Pubitemid 23257778)
18. Costello AH, Hargreaves KM: Suppression of carrageenaninduced hyperalgesia, hyperthermia and edema by a bradykinin antagonist. Eur J Pharmacol 1989; 171:259-63 (Pubitemid 19284120)
19. Davis AJ, Perkins MN: Induction of B1 receptors in vivo in a model of persistent inflammatory mechanical hyperalgesia in the rat. Neuropharmacology 1994; 33:127-33
20. Poole S, Lorenzetti BB, Cunha JM, Cunha FQ, Ferreira SH: Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br J Pharmacol 1999; 126:649-56 (Pubitemid 29087843)
21. Rupniak NM, Boyce S, Webb JK, Williams AR, Carlson EJ, Hill RG, Borkowski JA, Hess JF: Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice. Pain 1997; 71:89-97 (Pubitemid 27245235)
22. Wang H, Kohno T, Amaya F, Brenner GJ, Ito N, Allchorne A, Ji RR, Woolf CJ: Bradykinin produces pain hypersensitivity by potentiating spinal cord glutamatergic synaptic transmission. J Neurosci 2005; 25:7986-92 (Pubitemid 41254401)
23. Boyce S, Rupniak NM, Carlson EJ, Webb J, Borkowski JA, Hess JF, Strader CD, Hill RG: Nociception and inflammatory hyperalgesia in B2 bradykinin receptor knockout mice. Immunopharmacology 1996; 33:333-5 (Pubitemid 26247961)
24. Ferreira J, Campos MM, Pesquero JB, Araujo RC, Bader M, Calixto JB: Evidence for the participation of kinins in Freund's adjuvant-induced inflammatory and nociceptive responses in kinin B1 and B2 receptor knockout mice. Neuropharmacology 2001; 41:1006-12 (Pubitemid 34024996)
25. Porreca F, Vanderah TW, Guo W, Barth M, Dodey P, Peyrou V, Luccarini JM, Junien JL, Pruneau D: Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H- imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist. J Pharmacol Exp Ther 2006; 318:195-205
26. Ferreira J, Campos MM, Araujo R, Bader M, Pesquero JB, Calixto JB: The use of kinin B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal levE.L. Neuropharmacology 2002; 43:1188-97 (Pubitemid 36013455)
27. Fox A, Wotherspoon G, McNair K, Hudson L, Patel S, Gentry C, Winter J: Regulation and function of spinal and peripheral neuronal B1 bradykinin receptors in inflammatory mechanical hyperalgesia. Pain 2003; 104:683-91 (Pubitemid 37289068)
28. Pesquero JB, Araujo RC, Heppenstall PA, Stucky CL, Silva JA Jr, Walther T, Oliveira SM, Pesquero JL, Paiva AC, Calixto JB, Lewin GR, Bader M: Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci U S A 2000; 97:8140-5 (Pubitemid 30460786)
29. Fox A, Kaur S, Li B, Panesar M, Saha U, Davis C, Dragoni I, Colley S, Ritchie T, Bevan S, Burgess G, McIntyre P: Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor. Br J Pharmacol 2005; 144:889-99 (Pubitemid 40593014)
30. Ferreira J, Beirith A, Mori MA, Araujo RC, Bader M, Pesquero JB, Calixto JB: Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice. J Neurosci 2005; 25:2405-12 (Pubitemid 40322282)
31. Gougat J, Ferrari B, Sarran L, Planchenault C, Poncelet M, Maruani J, Alonso R, Cudennec A, Croci T, Guagnini F, Urban-Szabo K, Martinolle JP, Soubrié P, Finance O, Le Fur G: SSR240612 [(2R)-2-[((3R)-3-(1,3- benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino] -3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N- methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: Biochemical and pharmacological characterization. J Pharmacol Exp Ther 2004; 309:661-9 (Pubitemid 38542620)
32. Petcu M, Dias JP, Ongali B, Thibault G, Neugebauer W, Couture R: Role of kinin B1 and B2 receptors in a rat model of neuropathic pain. Int Immunopharmacol 2008; 8:188-96
33. Yamaguchi-Sase S, Hayashi I, Okamoto H, Nara Y, Matsuzaki S, Hoka S, Majima M: Amelioration of hyperalgesia by kinin receptor antagonists or kininogen deficiency in chronic constriction nerve injury in rats. Inflamm Res 2003; 52:164-9 (Pubitemid 36535265)
34. Allogho SN, Gobeil F, Pheng LH, Nguyen-Le XK, Neugebauer W, Regoli D: Kinin B1 and B2 receptors in the mouse. Can J Physiol Pharmacol 1995; 73:1759-64
35. Bawolak MT, Fortin JP, Vogel LK, Adam A, Marceau F: The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: Off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors. Eur J Pharmacol 2006; 551:108-11 (Pubitemid 44648059)
36. Seabrook GR, Bowery BJ, Heavens R, Brown N, Ford H, Sirinathsinghi DJ, Borkowski JA, Hess JF, Strader CD, Hill RG: Expression of B1 and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice. Neuropharmacology 1997; 36:1009-17 (Pubitemid 27300131)
37. Cayla C, Todiras M, Iliescu R, Saul VV, Gross V, Pilz B, Chai G, Merino VF, Pesquero JB, Baltatu OC, Bader M: Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J 2007; 21:1689-98 (Pubitemid 46855614)
38. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53:55-63 (Pubitemid 24238751)
39. Labuz D, Schmidt Y, Schreiter A, Rittner HL, Mousa SA, Machelska H: Immune cell-derived opioids protect against neuropathic pain in mice. J Clin Invest 2009; 119:278-86
40. Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32:77-88
41. Caspani O, Zurborg S, Labuz D, Heppenstall PA: The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS One 2009; 4:e7383
42. Ferreira J, da Silva GL, Calixto JB: Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol 2004; 141: 787-94 (Pubitemid 38446179)
43. Le Bars D, Gozariu M, Cadden SW: Animal models of nociception. Pharmacol Rev 2001; 53:597-652 (Pubitemid 33136239)
44. Ness TJ: Models of visceral nociception. ILAR J 1999; 40: 119-28 (Pubitemid 129663198)
45. Whittle BA: Release of a kinin by intraperitoneal injection of chemical agents in mice. Int J Neuropharmacol 1964; 3:369-78
46. Ballou LR, Botting RM, Goorha S, Zhang J, Vane JR: Nociception in cyclooxygenase isozyme-deficient mice. Proc Natl Acad Sci USA 2000; 97:10272-6
47. Steranka LR, Manning DC, DeHaas CJ, Ferkany JW, Borosky SA, Connor JR, Vavrek RJ, Stewart JM, Snyder SH: Bradykinin as a pain mediator: Receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc Natl Acad Sci U S A 1988; 85:3245-9
48. Brierley SM, Jones RC, 3rd, Xu L, Gebhart GF, Blackshaw LA: Activation of splanchnic and pelvic colonic afferents by bradykinin in mice. Neurogastroenterol Motil 2005; 17: 854-62 (Pubitemid 41746524)
49. Longhurst JC, Kaufman MP, Ordway GA, Musch TI: Effects of bradykinin and capsaicin on endings of afferent fibers from abdominal visceral organs. Am J Physiol 1984; 247:R552-9 (Pubitemid 14003646)
50. Mizumura K, Minagawa M, Tsujii Y, Kumazawa T: The effects of bradykinin agonists and antagonists on visceral polymodal receptor activitiE.S. Pain 1990; 40:221-7 (Pubitemid 20070790)
51. Corrêa CR, Kyle DJ, Chakraverty S, Calixto JB: Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice. Br J Pharmacol 1996; 117: 552-8 (Pubitemid 26057657)
52. Ikeda Y, Ueno A, Naraba H, Oh-ishi S: Involvement of vanilloid receptor VR1 and prostanoids in the acid-induced writhing responses of mice. Life Sci 2001; 69: 2911-9 (Pubitemid 33030279)
53. Blais C Jr, Leclair P, Molinaro G, Adam A: Absence of effect of chronic angiotensin II type 1 receptor blockade on endogenous kinin concentrations- induced paw edema model in the rat. Peptides 1999; 20:343-52 (Pubitemid 29425846)
54. Decarie A, Adam A, Couture R: Effects of captopril and Icatibant on bradykinin (BK) and des [Arg9] BK in carrageenan-induced edeM.A. Peptides 1996; 17:1009-15 (Pubitemid 26355328)
55. Ikeda Y, Ueno A, Naraba H, Oh-ishi S: Evidence for bradykinin mediation of carrageenin-induced inflammatory pain: A study using kininogen-deficient Brown Norway Katholiek rats. Biochem Pharmacol 2001; 61:911-4 (Pubitemid 32248712)
56. Morris CJ: Carrageenan-induced paw edema in the rat and mouse. Methods Mol Biol 2003; 225:115-21
57. Stein C, Millan MJ, Herz A: Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: Alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav 1988; 31:445-51 (Pubitemid 19275167)
58. Perkins MN, Campbell E, Dray A: Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat. Pain 1993; 53:191-7 (Pubitemid 23161582)
59. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS, Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M: Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception. Pain 1999; 80:67-82 (Pubitemid 29151691)
60. Levy D, Zochodne DW: Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain. Pain 2000; 86:265-71 (Pubitemid 30254267)
61. Petersen M, Eckert AS, Segond von Banchet G, Heppelmann B, Klusch A, Kniffki KD: Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury. Neuroscience 1998; 83:949-59 (Pubitemid 28068913)
62. Rashid MH, Inoue M, Matsumoto M, Ueda H: Switching of bradykinin-mediated nociception following partial sciatic nerve injury in mice. J Pharmacol Exp Ther 2004; 308: 1158-64 (Pubitemid 38263993)
63. Werner MF, Kassuya CA, Ferreira J, Zampronio AR, Calixto JB, Rae GA: Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats. Neuropharmacology 2007; 53:48-57 (Pubitemid 47125942)
64. Stein C, Machelska H: Modulation of peripheral sensory neurons by the immune system: Implications for pain therapy. Pharmacol Rev 2011; 63:860-81
65. Moalem G, Tracey DJ: Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006; 51:240-64 (Pubitemid 43902971)
66. Mousa SA, Cheppudira BP, Shaqura M, Fischer O, Hofmann J, Hellweg R, Schäfer M: Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain 2007; 130:502-13 (Pubitemid 46181103)
67. Puehler W, Rittner HL, Mousa SA, Brack A, Krause H, Stein C, Schäfer M: Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation. Neuroscience 2006; 141:989-98 (Pubitemid 44102698)
68. Kabli N, Cahill CM: Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 2007; 127: 84-93 (Pubitemid 44959432)
69. Obara I, Przewlocki R, Przewlocka B: Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats. Neurosci Lett 2004; 360:85-9 (Pubitemid 38471994)
70. Shinoda K, Hruby VJ, Porreca F: Antihyperalgesic effects of loperamide in a model of rat neuropathic pain are mediated by peripheral delta-opioid receptors. Neurosci Lett 2007; 411:143-6 (Pubitemid 44820680)
71. Walker J, Catheline G, Guilbaud G, Kayser V: Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats. Pain 1999; 83:509-16